NeuroFrontiers

Despite the high prevalence of multiple sclerosis (MS), there’s still a lot we don’t know about this disease. One such area of uncertainty is in regard to how MS causes the immune system to become dysfunctional, but this knowledge is key as it could help us develop new treatment options. And now, we might be one step closer to discovering those treatments thanks to a recent study exploring specific T cells, and joining Dr. Jerome Lisk to discuss that study is Dr. Shiva Othy, a Project Scientist in the Department of Physiology and Biophysics at the University of California Irvine School of Medicine.

Although there’s currently no cure for schizophrenia, it can be managed with therapy and medication—for some patients, that is. In fact, up to one-half of patients with severe symptoms don’t respond to medication. So how are we to care for this large percentage of patients living with treatment-resistant schizophrenia? That’s the question Dr. Andrew Wilner asks Dr. Nicola Cascella, an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine who recently conducted a case study exploring the potential use of deep brain stimulation for patients with treatment-resistant schizophrenia.

Relapsing forms of multiple sclerosis can progress quickly and aggressively. What should our patients be looking out for? Dr. Charles Turck is joined by Dr. Lauren Gluck to discuss how we can help patients cope with progressing RMS.

What can we do better to recognize relapsing multiple sclerosis in our patients? Dr. Iris V. Marin Collazo joins Dr. Jennifer Caudle to discuss key signs of progression and critical clinical tools to help measure it.

What does the patient journey in multiple sclerosis progression look like? Dr. Charles Turck is joined by Dr. Michael Kornberg to discuss the impact of early detection and share strategies to help manage the burden of this disease.

Dr. Dawn Eliashiv of the University of California—Los Angeles and Dr. Karen Keough of the Child Neurology Consultants of Austin, Texas discuss using EPIDIOLEX® to treat patients 1 year of age or older with seizures associated with LGS, Dravet syndrome, or TSC.

According to recent estimates, between 150,000 and 450,000 transgender patients have epilepsy. And as that number is only expected to grow, Assistant Professor of Neurology at Johns Hopkins School of Medicine Dr. Emily Johnson shares key considerations for treating transgender patients with epilepsy.

Tune in to hear Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, discuss her study on mental health in women and how we can take a more targeted treatment approach.

Traumatic brain injury, or TBI, manifests differently in men and women. Here to explore these differences is Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, meets with Dr. Andrew Wilner to discuss traumatic brain injuries in female patients.

Traumatic brain injury, or TMI, manifests differently in men and women. Here to explore these differences is Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, meets with Dr. Andrew Wilner to discuss traumatic brain injuries in female patients.